ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 256 filers reported holding ARGENX SE in Q3 2022. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,517,182 | +26.2% | 3,528 | +15.5% | 0.00% | +100.0% |
| Q1 2024 | $1,202,421 | +29.5% | 3,054 | +25.1% | 0.00% | -50.0% |
| Q4 2023 | $928,628 | -28.3% | 2,441 | -7.4% | 0.00% | 0.0% |
| Q3 2023 | $1,295,445 | +96.5% | 2,635 | +55.7% | 0.00% | +100.0% |
| Q2 2023 | $659,423 | +83.8% | 1,692 | +75.7% | 0.00% | 0.0% |
| Q1 2023 | $358,795 | -5.9% | 963 | -4.3% | 0.00% | 0.0% |
| Q4 2022 | $381,103 | +10.5% | 1,006 | +3.0% | 0.00% | 0.0% |
| Q3 2022 | $345,000 | +65.1% | 977 | +77.3% | 0.00% | – |
| Q2 2022 | $209,000 | – | 551 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 285,198 | $106,259,071 | 29.06% |
| Avoro Capital Advisors LLC | 1,287,500 | $479,696,750 | 7.11% |
| Paradigm Biocapital Advisors LP | 181,172 | $67,501,064 | 6.40% |
| DCF Advisers, LLC | 25,700 | $9,575,310 | 5.86% |
| Artia Global Partners LP | 36,404 | $13,563,402 | 5.01% |
| Bellevue Group AG | 886,928 | $330,451,634 | 4.80% |
| Fairmount Funds Management LLC | 73,526 | $27,394,317 | 4.71% |
| Eagle Health Investments LP | 64,400 | $23,994,152 | 4.67% |
| Decheng Capital Management III (Cayman), LLC | 27,429 | $10,219,497 | 4.12% |
| RTW INVESTMENTS, LP | 482,195 | $179,656,213 | 3.74% |